Therapeutic effect of vitamin B3 on hyperglycemia, oxidative stress and DNA damage in alloxan induced diabetic rat model

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
K M AbdullahImrana Naseem

Abstract

Evidences in the form of experimental analysis and scientific investigations suggest that oxidative stress embody an imperative role in the onset and progression of type-2 diabetes mellitus (T2DM). Aberrant elevation in levels of free radicals, as observed upon disease onset, and the subsequent reduction in anti-oxidant defenses is pernicious to metabolic enzymes and cellular organelles. Niacin (Vitamin B3) is an essential nutrient for humans and is considered to be an important food additive for animals too. This research was conducted to examine the effect of nutraceutical antioxidant on diabetic environment. This important member of Vitamin B complex is a forerunner of nicotinamide adenine dinucleotide (NAD) and also nicotinamide adenine dinucleotide phosphate (NADP), both of them serving as coenzymes for several metabolic enzymes. This study reports the effects of niacin supplementation in alloxan induced diabetic rats divided into five groups. Diabetes induced rats were further treated with niacin at two doses (10 and 15 mg /kg body weight) and compared with a control set of diabetes without treatment. Niacin treatment showed recovery in almost all parameters in a dose reliant pattern. A notable decline in oxidative stress...Continue Reading

References

Jan 1, 1978·Methods in Enzymology·J A Buege, S D Aust
Jul 1, 1991·Clinical Pharmacology and Therapeutics·R H SternA Parbtani
Dec 31, 1990·Biochemical and Biophysical Research Communications·C J MullarkeyM Brownlee
Mar 1, 1988·Experimental Cell Research·N P SinghE L Schneider
Jan 1, 1984·Methods in Enzymology·H Aebi
Jan 1, 1994·Methods in Enzymology·R L LevineE Shacter
Jan 23, 1999·The American Journal of Cardiology·J R Guyton
Feb 4, 2003·Nature Medicine·Sorin TunaruStefan Offermanns
Nov 1, 1954·Journal of Clinical Pathology·P R KIND, E J KING
May 1, 1956·Archives of Biochemistry and Biophysics·K H SHULLJ MAYER
Jul 1, 1957·American Journal of Clinical Pathology·S REITMAN, S FRANKEL
Feb 1, 1955·Archives of Biochemistry and Biophysics·R ALTSCHULJ D STEPHEN
Dec 3, 2005·The Journal of Clinical Investigation·Zoltán BenyóStefan Offermanns
Apr 22, 2006·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Antonio Ceriello
Nov 30, 2006·PLoS Medicine·Colin D Mathers, Dejan Loncar
Sep 30, 2014·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Mohamed A DkhilAhmed E Abdel Moneim
Oct 28, 2014·CNS & Neurological Disorders Drug Targets·Nazir M KhanGhulam M Ashraf
Jan 1, 2013·Journal of Biomarkers·Brahm Kumar TiwariSyed Ibrahim Rizvi
Oct 19, 2016·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Ullah AsmatKhan Ismail
Jun 19, 2017·Archives of Biochemistry and Biophysics·K M AbdullahImrana Naseem

❮ Previous
Next ❯

Citations

Mar 29, 2019·International Journal of Molecular Sciences·Kai WangLiping Wang
Jul 6, 2019·Biomolecules & Therapeutics·Ao Xuan ZhenJin Won Hyun
Jul 23, 2020·Nature Metabolism·Elena KatsyubaJohan Auwerx
Jun 29, 2021·Journal of Diabetes and Metabolic Disorders·Aaishwarya Deshmukh, Prajakta Manjalkar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.